- Home
- SABA vs SMTI Comparison
SABA vs SMTI Comparison
Compare SABA & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABA
- SMTI
- Stock Information
- Founded
- SABA 1988
- SMTI 1982
- Country
- SABA United States
- SMTI United States
- Employees
- SABA N/A
- SMTI N/A
- Industry
- SABA
- SMTI Medical/Dental Instruments
- Sector
- SABA
- SMTI Health Care
- Exchange
- SABA Nasdaq
- SMTI Nasdaq
- Market Cap
- SABA 246.4M
- SMTI 252.1M
- IPO Year
- SABA N/A
- SMTI N/A
- Fundamental
- Price
- SABA $9.13
- SMTI $29.84
- Analyst Decision
- SABA
- SMTI Strong Buy
- Analyst Count
- SABA 0
- SMTI 2
- Target Price
- SABA N/A
- SMTI $49.50
- AVG Volume (30 Days)
- SABA 290.0K
- SMTI 51.0K
- Earning Date
- SABA 01-01-0001
- SMTI 08-11-2025
- Dividend Yield
- SABA 12.91%
- SMTI N/A
- EPS Growth
- SABA N/A
- SMTI N/A
- EPS
- SABA N/A
- SMTI N/A
- Revenue
- SABA N/A
- SMTI $91,569,883.00
- Revenue This Year
- SABA N/A
- SMTI $23.53
- Revenue Next Year
- SABA N/A
- SMTI $5.93
- P/E Ratio
- SABA N/A
- SMTI N/A
- Revenue Growth
- SABA N/A
- SMTI 34.65
- 52 Week Low
- SABA $3.64
- SMTI $25.86
- 52 Week High
- SABA $4.42
- SMTI $39.08
- Technical
- Relative Strength Index (RSI)
- SABA 64.47
- SMTI 53.37
- Support Level
- SABA $9.08
- SMTI $29.80
- Resistance Level
- SABA $9.29
- SMTI $30.94
- Average True Range (ATR)
- SABA 0.11
- SMTI 1.07
- MACD
- SABA -0.00
- SMTI 0.29
- Stochastic Oscillator
- SABA 69.70
- SMTI 73.17
About SABA Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest
Saba Capital Income & Opportunities Fund II is a closed-end fund. The company seeks high current income, with a secondary goal of capital appreciation. The fund invests in fixed income markets across the globe.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.